期刊
JOURNAL OF NEUROINFLAMMATION
卷 10, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1742-2094-10-153
关键词
Fetal Sheep; Inflammation; Pre-oligodendrocyte; AMPA; NMDA; NBQX; MK801; COX-2; in vitro
资金
- Health Research Council of New Zealand (HRC)
- Kelliher Charitable Trust
- HRC
Background: White matter injury (WMI) is the major antecedent of cerebral palsy in premature infants, and is often associated with maternal infection and the fetal inflammatory response. The current study explores the therapeutic potential of glutamate receptor blockade or cyclooxygenase-2 (COX-2) inhibition for inflammatory WMI. Methods: Using fetal ovine derived mixed glia cultures exposed to tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS), the expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) and N-methyl D-aspartate (NMDA) glutamate receptors and their contribution to inflammation mediated pre-oligodendrocyte (OL) death was evaluated. The functional significance of TNF-alpha and COX-2 signalling in glutamate release in association with TNF-alpha and LPS exposure was also assessed. Results: AMPA and NMDA receptors were expressed in primary mixed glial cultures on developing OLs, the main cell-type present in fetal white matter at a period of high risk for WMI. We show that glutamate receptor expression and configuration are regulated by TNF-alpha and LPS exposure, but AMPA and NMDA blockade, either alone or in combination, did not reduce pre-OL death. Furthermore, we demonstrate that glutamate and prostaglandin E2 (PGE2) release following TNF-a or LPS are mediated by a TNF-alpha-COX-2 dependent mechanism. Conclusions: Overall, these findings suggest that glial-localised glutamate receptors likely play a limited role in OL demise associated with chronic inflammation, but supports the COX-2 pathway as a potential therapeutic target for infection/inflammatory-mediated WMI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据